Efficient genome editing in zebrafish using a CRISPR-Cas systemWoong Y. Hwang, J. Keith Joung, Yanfang Fu et al.|Nature Biotechnology|2013Cited by 3k
Engineered CRISPR-Cas9 nucleases with altered PAM specificitiesBenjamin P. Kleinstiver, J. Keith Joung, Michelle S. Prew et al.|Nature|2015Cited by 1.7k
In vivo drug discovery in the zebrafishLeonard I. Zon, Randall T. Peterson|Nature Reviews Drug Discovery|2005Cited by 1.4k
Targeted gene disruption in somatic zebrafish cells using engineered TALENsJeffry D. Sander, Jing-Ruey Joanna Yeh, Randall T. Peterson et al.|Nature Biotechnology|2011Cited by 628
A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathyDulguun Amgalan, Richard N. Kitsis, Thomas P. Garner et al.|Nature Cancer|2020Cited by 123